4101.0: Tuesday, November 18, 2003: 12:30 PM-2:00 PM | |||
Poster | |||
| |||
Learning Objectives: Refer to the individual abstracts for learning objectives | |||
See individual abstracts for presenting author's disclosure statement and author's information. | |||
A randomized trial of accelerated vs. standard hepatitis B virus immunization in young IDU in San Francisco, the UFO Study Paula J Lum, MD MPH, Judy Hahn, PhD, Kimberly Page Shafer, PhD, Jennifer Evans, MS, Peter J Davidson, BA, Ellen Stein, MPH, Susan E. Fernyak, MD, MPH, Andrew R Moss, PhD | |||
Alcohol use among hepatitis C virus antibody positive injection drug users in three US cities Jennifer Vernon Campbell, MSPH, Holly Hagan, PhD, Mary Latka, PhD, Richard S Garfein, PhD, MPH, Elizabeth T. Golub, PhD, MPH, David L. Thomas, MD, MPH, Steffanie A. Strathdee, PhD | |||
Associations between STIs and prevalent HIV infection among injection and non-injection young drug users Susan G. Sherman, MPH, PhD, Sabrina Plitt, MPH, Marcella Sapun, Crystal Fuller, MPH, PhD, Steffanie Strathdee, PhD | |||
Circumstances surrounding the first injection episode and association with future needle sharing among young injection drug users Laura A. Novelli, Susan G. Sherman, MPH, PhD, Jennifer R Havens, MPH, Marcella Sapun, Crystal Fuller, MPH, PhD, Steffanie A. Strathdee, PhD | |||
Crack injection in New York: Narrative accounts of recent injection events Stephen E. Lankenau, PhD, Michael Clatts, PhD, Lloyd Goldsamt, PhD | |||
HIV among new injecting drug users in New York City, 1990-2001: Divergence among race/ethnic groups Don C. Des Jarlais, PhD, Theresa E. Perlis, PhD, Kaymar Arasteh, PhD, Holly Hagan, PhD, Carey Maslow, PhD, Judith Milliken, Naomi Braine, PhD, Alan Neaigus, PhD, Samuel R. Friedman, PhD | |||
Impact of syringe type on HIV and HCV epidemics among injecting drug users William A. Zule, DrPH, Wendee Wechsberg, PhD, Wendy K.K. Lam, PhD, Winnie Luseno | |||
Non-injecting heroin users (NIHU) in Chicago: Initiation, continued use and attitudes toward drug injection Dita A. Davis, Lawrence J. Ouellet, PhD | |||
Who enters higher quality drug treatment: Injection drug users and differences in human capital and institutional affiliation Lena M. Lundgren, PhD, Robert F. Schilling, PhD, Faith Ferguson, PhD, Karen A. Davis, MSW, MPH, Maryann Amodeo, PhD | |||
Acceptability and utility of a syringe disposal device for active injection drug users (IDUs) Francis A. Wolf, BA, Michelle McKenzie, MPH, Stephanie L Sanford-Colby, MPH, Rachel S. Weston, BA, Grace E Macalino, PhD, Josiah D. Rich, MD, MPH | |||
Organized by: | Alcohol, Tobacco, and Other Drugs |